What is physIQ?
physIQ operates at the intersection of advanced data science and clinical medicine, providing an enterprise-grade cloud platform that processes continuous physiological data from wearable biosensors. The company distinguishes itself through a deep portfolio of FDA-cleared artificial intelligence analytics, which are designed to generate unprecedented health insights. By transforming raw sensor data into clinically validated metrics, physIQ supports pharmaceutical companies in clinical trial optimization and assists healthcare providers in delivering proactive, data-driven patient care. Its market position is defined by a rigorous commitment to clinical validation, making it a preferred partner for organizations seeking to integrate high-fidelity, continuous monitoring into their operational workflows.
How much funding has physIQ raised?
physIQ has raised a total of $19.9M across 5 funding rounds:
Series A
$4.6M
Private Equity
$3.6M
Series B
$8M
Unspecified
$3.3M
Debt
$350K
Series A (2014): $4.6M with participation from LionBird Ltd.
Private Equity (2016): $3.6M, investors not publicly disclosed
Series B (2017): $8M supported by LionBird, GF Securities, Quark Venture Inc., and 4490 Ventures
Unspecified (2019): $3.3M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in physIQ
LionBird
LionBird is a venture capital firm specializing in early-stage health-tech startups that aim to transform the healthcare landscape through innovative technology. They provide pre-scale capital and strategic support to teams dedicated to improving healthcare solutions.
Quark Venture Inc.
Quark Venture LP is a venture capital firm focused on equity financing for innovative biotechnology companies with breakthrough technology platforms. They support entrepreneurial firms to efficiently improve technology platforms and achieve high-growth value.
GF Securities
GF Securities is a prominent financial services firm that provides comprehensive investment banking and asset management services, often participating in strategic growth rounds for high-potential technology enterprises.
What's next for physIQ?
With the recent influx of capital, physIQ is well-positioned to scale its enterprise operations and expand its footprint in the global digital health market. The strategic focus will likely center on deepening the integration of its AI-based analytics within existing healthcare ecosystems and enhancing the scalability of its cloud platform to accommodate increasing data volumes from diverse wearable devices. As the industry shifts toward decentralized clinical trials and continuous patient monitoring, physIQ is poised to leverage its regulatory-approved technology to capture significant market share. Future growth initiatives will likely prioritize the expansion of its clinical trial support services and the development of new predictive models that further improve patient outcomes and operational efficiency for its enterprise clients.
See full physIQ company page
